| JXHL1200210 | AVE8062注射液 | ombrabulin | Injection | Chemical Drugs | Import Drug Application | 2012-07-09 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi-Aventis Recherche & Developpement | Certificate Issued | 2013-03-06 | view |
| JXSL2000230 | BIVV020注射液 | riliprubart | Injection | Biological Products(1) | Import Drug Application | 2020-12-16 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi-Aventis Recherche & Developpement | In Review | 2020-12-15 | view |
| JYSB2000325 | cemiplimab注射液 | cemiplimab | Injection | Biological Products | Supplementary Application | 2020-07-03 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Catalent Indiana LLC;Sanofi-Aventis Recherche & Developpement | In Review | 2020-07-02 | view |
| JXSL2000165 | cemiplimab注射液 | cemiplimab | Injection | Biological Products(2.2) | Import Drug Application | 2020-09-29 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi-Aventis Recherche & Developpement | In Review | 2020-09-28 | view |
| JYSB2000326 | cemiplimab注射液 | cemiplimab | Injection | Biological Products | Supplementary Application | 2020-07-03 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Catalent Indiana LLC;Sanofi-Aventis Recherche & Developpement | In Review | 2020-07-02 | view |
| JXSL2000139 | cemiplimab注射液 | cemiplimab | Injection | Biological Products(2.2) | Import Drug Application | 2020-08-03 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi-Aventis Recherche & Developpement | In Review | 2020-07-31 | view |
| JYSB1800311 | Efpeglenatide注射液 | efpeglenatide | Injection | Biological Products | Supplementary Application | 2019-01-14 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Hanmi Pharm Co Ltd;Sanofi-Aventis Recherche & Developpement | Certificate Issued | 2019-03-15 | view |
| JXSL1800033 | Efpeglenatide注射液 | efpeglenatide | Injection | Biological Products | Import Drug Application | 2018-09-21 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi-Aventis Recherche & Developpement | In Review | 2018-09-20 | view |
| JYSB1800313 | Efpeglenatide注射液 | efpeglenatide | Injection | Biological Products | Supplementary Application | 2019-01-14 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Hanmi Pharm Co Ltd;Sanofi-Aventis Recherche & Developpement | Certificate Issued | 2019-03-15 | view |
| JXSL1800035 | Efpeglenatide注射液 | efpeglenatide | Injection | Biological Products | Import Drug Application | 2018-09-21 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi-Aventis Recherche & Developpement | In Review | 2018-09-20 | view |
| JYSB1800312 | Efpeglenatide注射液 | efpeglenatide | Injection | Biological Products | Supplementary Application | 2019-01-14 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Hanmi Pharm Co Ltd;Sanofi-Aventis Recherche & Developpement | Certificate Issued | 2019-03-15 | view |
| JXSL1800034 | Efpeglenatide注射液 | efpeglenatide | Injection | Biological Products | Import Drug Application | 2018-09-21 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi-Aventis Recherche & Developpement | In Review | 2018-09-20 | view |
| JXSL1300060 | SAR236553注射液 | alirocumab | Injection | Biological Products | Import Drug Application | 2013-08-31 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi-Aventis Recherche & Developpement | Certificate Issued | 2015-12-03 | view |
| JXSL1400019 | SAR236553注射液 | alirocumab | Injection | Biological Products | Import Drug Application | 2014-04-17 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi-Aventis Recherche & Developpement | Certificate Issued | 2015-12-16 | view |
| JXSL1400020 | SAR236553注射液 | alirocumab | Injection | Biological Products | Import Drug Application | 2014-03-31 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi-Aventis Recherche & Developpement | Certificate Issued | 2015-12-16 | view |
| JXSL1400021 | SAR236553注射液 | alirocumab | Injection | Biological Products | Import Drug Application | 2014-03-31 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi-Aventis Recherche & Developpement | Certificate Issued | 2015-12-16 | view |
| JXSL1300059 | SAR236553注射液 | alirocumab | Injection | Biological Products | Import Drug Application | 2013-08-31 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi-Aventis Recherche & Developpement | Certificate Issued | 2015-12-03 | view |
| JXSL1300058 | SAR236553注射液 | alirocumab | Injection | Biological Products | Import Drug Application | 2013-09-11 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi-Aventis Recherche & Developpement | Certificate Issued | 2015-12-03 | view |
| JXSL1300061 | SAR236553注射液 | alirocumab | Injection | Biological Products | Import Drug Application | 2013-08-31 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi-Aventis Recherche & Developpement | Certificate Issued | 2015-12-03 | view |
| JXSL1400022 | SAR236553注射液 | alirocumab | Injection | Biological Products | Import Drug Application | 2014-03-31 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi-Aventis Recherche & Developpement | Certificate Issued | 2015-12-16 | view |
